dc 4

DC4 can be used to synthesize antibody-drug conjugate (ADC), which is an ADC cytotoxin. DC4 can be used for targeted therapy of tumors.

DC4 crosslinker, an 18Å mass spectrometry-cleavable crosslinking reagent, features two intrinsic positive charges facilitating the fragmentation of cross-linked peptides into their constituent peptides through collision-induced dissociation or in-source decay. Initial fragmentation leads to cleavage adjacent to the positive charges, enabling the identification of cross-linked peptides as pairs of ions with precise mass separation. Furthermore, the resultant intact peptide fragments can undergo further fragmentation, producing a sequence of b- and y-ions for peptide identification.

The IC50s of DC4SMe on Ramos, Namalwa and HL60 s cancer cells were 1.9 nM, 2.9 nM and 1.8 nM, respectively. DC4SMe can be used for targeted therapy of tumors. DC4SMe is a phosphate prodrug of the cytotoxic DNA alkylating agent DC4 and can be used in the

5’-O-DMT-N4-Ac-2’-F-dC is a modified nucleoside and can be used to synthesize DNA or RNA.

5’-O-DMT-N4-Bz-2’-F-dC is a nucleoside with protective and modification effects.

5'-O-DMT-N4-Bz-5-Me-dC (DMT-NBZ-5-METHYL DC) 是一种修饰的核苷，可用于合成核苷磷酰胺。

5'-O-DMT-N4-Ac-dC (N4-Acetyl-2'-deoxy-5'-O-DMT-cytidine, compound 7) is a deoxynucleoside utilized in the synthesis of dodecyl phosphoramidite. Dodecyl phosphoramidite serves as a crucial precursor for dod-DNA production, which is amphiphilic DNA comprising dodecyl phosphotriester linkages and featuring an internal hydrophobic region[1][2].

4-CF3-TPP-DC is an inert mitochondriotropic carrier that does not induce mitochondrial depolarization or cell death in C2C12 cells.

A2-Iso5-4DC19 为类脂化合物，有效递送多核苷酸等物质至细胞内，作为高效载体。

A12-Iso5-4DC19 是一种能够电离的阳离子脂质，促进 mRNA 的传递，适用于 RNA 疫苗研究。

5'-O-DMTr-N4-Fmoc-5-Me-dC-phosphoramidite is a Nucleoside Phosphoramidite.

DC 432是一种强效的N-terminal methyltransferase 1 2 (NTMT1 2) (IC50= 54 nM)肽模拟抑制剂，含有BM30肽和额外五个精氨酸残基。在HCT116细胞中，DC 432处理能够降低调节染色体凝缩1和SET蛋白的N端甲基化水平。该化合物具有细胞渗透性。

AZA197 (AZA-197)是一种选择性 Cdc42抑制剂。在临床前小鼠异种移植模型中，它通过下调 PAK1活性来抑制原发性结肠癌的生长并延长生存期。

DC41SMe is a DC1 derivative that is cytotoxic to Ramos, Namalwa and HL60 s with IC50s ranging from 18-25 pM. DC1 is a simplified analogue of CC-1065, an antibody conjugate of cytotoxic DNA alkylation molecules, used for targeted treatment of cancer.

DC41 is a derivative of DC1. DC1 is a simplified analogue of CC-1065, an antibody conjugate of cytotoxic DNA alkylating agents, used for targeted treatment of cancer.

The IC50 of DC44SMe for Ramos, Namalwa and HL60 s cancer cells was 2.0 nM, 2.8 nM and 1.9 nM, respectively. DC44SMe can be used for targeted treatment of cancer. DC44SMe is a phosphate prodrug of DC44 and can be used in the synthesis of antibody-drug co

CUDC-427 (GDC-0917) 是一种具有口服生物活性的泛拮抗剂，是凋亡蛋白抑制剂 (IAP) 的拮抗剂。 CUDC-427 可用于癌症研究。

MBQ-167 是一种 Rac Cdc42 的双重抑制剂，在 MDA-MB-231 细胞中，Rac 1 2 3 和 Cdc42 的 IC50 分别为 103 nM 和 78 nM。

CASIN (Pirl1-related Compound 2) 是选择性GTPase Cdc42抑制剂，IC50值是 2 uM。

LDC4297 (LDC044297)是 CDK7的一种高效选择性抑制剂，IC50值为0.13 nM。

LDC-4297 HCl (1453834-21-3(free base)) 是一种有效的选择性 CDK7 抑制剂，IC50 为 0.13 nM。

AZA1 (Rac1 Cdc42-IN-1) 是一种有效的Rac1和Cdc42双重抑制剂。AZA1 诱导前列腺癌细胞凋亡，抑制癌细胞增殖，迁移和侵袭。

GDC-4379 是 JAK1 抑制剂，能够用于研究哮喘。

CB-5083 是一种有效的、选择性的、可口服的 p97 AAA ATPase 抑制剂，IC50为 11 nM。